Nicholas Company, Inc. Bio Techne Corp Transaction History

Nicholas Company, Inc.

$5.89 Billion
Q2 2024

A detailed history of Nicholas Company, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Nicholas Company, Inc. holds 264,829 shares of TECH stock, worth $19.8 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

264,829

Previous 264,829 -0.0%

Holding current value

$19.8 Million

Previous $18.6 Million 1.79%

% of portfolio

0.32%

Previous 0.31%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $2.11 Million - $2.46 Million	31,970 Added 13.73%	264,829 $18.6 Million
Q4 2023 Feb 13, 2024	BUY	$52.83 - $78.22 $3.39 Million - $5.03 Million	64,250 Added 38.11%	232,859 $18 Million
Q3 2023 Feb 13, 2024	BUY	$67.52 - $89.42 $9.62 Million - $12.7 Million	142,510 Added 546.04%	168,609 $11.5 Million
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $9.62 Million - $12.7 Million	142,510 Added 546.04%	168,609 $11.5 Million
Q2 2023 Feb 13, 2024	SELL	$73.76 - $85.98 $10.5 Million - $12.3 Million	-142,510 Reduced 84.52%	26,099 $2.13 Million
Q2 2023 Aug 08, 2023	BUY	$73.76 - $85.98 $1.93 Million - $2.24 Million	26,099 New	26,099 $2.13 Million
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $5.1 Million - $6.18 Million	-11,475 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$387.35 - $450.26 $6.15 Million - $7.15 Million	-15,890 Reduced 58.07%	11,475 $5.17 Million
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $2.07 Million - $2.71 Million	-6,595 Reduced 19.42%	27,365 $10.5 Million
Q4 2020 Feb 10, 2021	BUY	$246.9 - $321.87 $1,234 - $1,609	5 Added 0.01%	33,960 $10.8 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $205,827 - $310,311	-1,110 Reduced 3.17%	33,955 $8.97 Million
Q4 2019 Feb 13, 2020	SELL	$189.68 - $222.09 $948 - $1,110	-5 Reduced 0.01%	35,065 $7.7 Million
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $5,661 - $6,462	-30 Reduced 0.09%	35,070 $7.31 Million
Q1 2019 May 14, 2019	SELL	$136.09 - $200.44 $10,206 - $15,033	-75 Reduced 0.21%	35,100 $6.97 Million
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $69,030 - $105,976	-520 Reduced 1.46%	35,175 $5.09 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $226,320 - $313,308	-1,535 Reduced 4.12%	35,695 $7.29 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $362,250 - $413,950	-2,500 Reduced 6.29%	37,230 $5.51 Million
Q1 2018 May 14, 2018	SELL	$131.46 - $151.04 $12,488 - $14,348	-95 Reduced 0.24%	39,730 $6 Million
Q3 2017 Nov 14, 2017	SELL	$113.59 - $123.78 $21,582 - $23,518	-190 Reduced 0.47%	39,825 $4.81 Million
Q2 2017 Aug 11, 2017	BUY	N/A	40,015	40,015 $4.7 Million

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.93B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account

Nicholas Company, Inc. Bio Techne Corp Transaction History